Table 4: Operational recommendations.
| 
				 Scenario  | 
			
				 Anticoagulant choice  | 
			
				 
  | 
		
| 
				 Processing≤2hours  | 
			
				 K₃EDTA  | 
			
				 Prioritize platelet studies  | 
		
| 
				 Delays(2-6hours)  | 
			
				 K₂EDTA  | 
			
				 AdjustMCV/RDW-SD referenceranges  | 
		
| 
				 All workflows  | 
			
				 N/A  | 
			
				 Document storage duration/anticoagulant < brr > -  |